Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,998 | 113,098 | 117,662 | 136,377 | 164,682 |
| Other current assets | 6,115 | 9,251 | 10,630 | 22,161 | 23,622 |
| TOTAL | $96,113 | $122,349 | $128,292 | $158,538 | $188,304 |
| Non-Current Assets | |||||
| PPE Net | 8,782 | 9,635 | 9,906 | 10,141 | 10,050 |
| Intangibles | 4 | 6 | 8 | 10 | 11 |
| Other Non-Current Assets | 57,235 | 64,183 | 2,919 | 2,077 | 2,689 |
| TOTAL | $66,021 | $73,824 | $12,833 | $12,228 | $12,750 |
| Total Assets | $162,134 | $196,173 | $141,125 | $170,766 | $201,054 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,881 | 9,141 | 5,187 | 5,665 | 4,550 |
| Accrued Expenses | 7,217 | 8,841 | 15,497 | 12,303 | 10,873 |
| TOTAL | $26,098 | $25,394 | $20,684 | $17,968 | $15,423 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 46,407 | 52,217 | 0 | 0 | 0 |
| TOTAL | $46,407 | $52,217 | $N/A | $N/A | $N/A |
| Total Liabilities | $72,505 | $77,611 | $20,684 | $17,968 | $15,423 |
| Shareholders' Equity | |||||
| Common Shares | 137 | 137 | 137 | 137 | 137 |
| Retained earnings | -407,461 | -383,114 | -356,381 | -321,681 | -290,805 |
| Other shareholders' equity | -1,496 | 6,742 | 9,472 | 9,057 | 14,195 |
| TOTAL | $89,629 | $118,562 | $120,441 | $152,798 | $185,631 |
| Total Liabilities And Equity | $162,134 | $196,173 | $141,125 | $170,766 | $201,054 |